Imagion Biosystems Current Valuation vs. EBITDA
| IBXXF Stock | USD 0.04 0.00 0.00% |
For Imagion Biosystems profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Imagion Biosystems to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Imagion Biosystems Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Imagion Biosystems's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Imagion Biosystems Limited over time as well as its relative position and ranking within its peers.
Imagion |
Imagion Biosystems EBITDA vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Imagion Biosystems's current stock value. Our valuation model uses many indicators to compare Imagion Biosystems value to that of its competitors to determine the firm's financial worth. Imagion Biosystems Limited is considered the number one company in current valuation category among its peers. It is rated third overall in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Imagion Biosystems' earnings, one of the primary drivers of an investment's value.Imagion Current Valuation vs. Competition
Imagion Biosystems Limited is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Diagnostics & Research industry is currently estimated at about 47.59 Billion. Imagion Biosystems adds roughly 21.85 Million in current valuation claiming only tiny portion of equities under Diagnostics & Research industry.
Imagion EBITDA vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Imagion Biosystems |
| = | 21.85 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Imagion Biosystems |
| = | (5.62 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Imagion EBITDA Comparison
Imagion Biosystems is currently under evaluation in ebitda category among its peers.
Imagion Biosystems Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Imagion Biosystems, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Imagion Biosystems will eventually generate negative long term returns. The profitability progress is the general direction of Imagion Biosystems' change in net profit over the period of time. It can combine multiple indicators of Imagion Biosystems, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. The company was incorporated in 2016 and is based in San Diego, California. Imagion Biosystems operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.
Imagion Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Imagion Biosystems. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Imagion Biosystems position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Imagion Biosystems' important profitability drivers and their relationship over time.
Use Imagion Biosystems in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Imagion Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imagion Biosystems will appreciate offsetting losses from the drop in the long position's value.Imagion Biosystems Pair Trading
Imagion Biosystems Limited Pair Trading Analysis
The ability to find closely correlated positions to Imagion Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Imagion Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Imagion Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Imagion Biosystems Limited to buy it.
The correlation of Imagion Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Imagion Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Imagion Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Imagion Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Imagion Biosystems position
In addition to having Imagion Biosystems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Trump Equities Thematic Idea Now
Trump Equities
Stocks that have significantly increased in valuation since Trump was elected president of the United States. The Trump Equities theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Trump Equities Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Imagion Pink Sheet
To fully project Imagion Biosystems' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Imagion Biosystems at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Imagion Biosystems' income statement, its balance sheet, and the statement of cash flows.